IN2011KN02819A - - Google Patents
Info
- Publication number
- IN2011KN02819A IN2011KN02819A IN2819KON2011A IN2011KN02819A IN 2011KN02819 A IN2011KN02819 A IN 2011KN02819A IN 2819KON2011 A IN2819KON2011 A IN 2819KON2011A IN 2011KN02819 A IN2011KN02819 A IN 2011KN02819A
- Authority
- IN
- India
- Prior art keywords
- relates
- humans
- animals
- viruses
- field
- Prior art date
Links
- 241001465754 Metazoa Species 0.000 abstract 3
- 241000700605 Viruses Species 0.000 abstract 2
- 238000011282 treatment Methods 0.000 abstract 2
- 208000036142 Viral infection Diseases 0.000 abstract 1
- 230000000840 anti-viral effect Effects 0.000 abstract 1
- 230000016396 cytokine production Effects 0.000 abstract 1
- 230000002950 deficient Effects 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 230000015788 innate immune response Effects 0.000 abstract 1
- 230000002452 interceptive effect Effects 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
- 230000004936 stimulating effect Effects 0.000 abstract 1
- 230000009385 viral infection Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/76—Viruses; Subviral particles; Bacteriophages
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16111—Influenzavirus A, i.e. influenza A virus
- C12N2760/16132—Use of virus as therapeutic agent, other than vaccine, e.g. as cytolytic agent
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16111—Influenzavirus A, i.e. influenza A virus
- C12N2760/16161—Methods of inactivation or attenuation
- C12N2760/16162—Methods of inactivation or attenuation by genetic engineering
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Virology (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Microbiology (AREA)
- Zoology (AREA)
- General Chemical & Material Sciences (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Molecular Biology (AREA)
- Epidemiology (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Mycology (AREA)
- Immunology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Pulmonology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0822672.2A GB0822672D0 (en) | 2008-12-12 | 2008-12-12 | Anti-viral protection with viruses containing a defective genome |
| PCT/GB2009/051666 WO2010067109A1 (en) | 2008-12-12 | 2009-12-08 | Anti-viral protection with viruses containing defective genome segments |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN2011KN02819A true IN2011KN02819A (https=) | 2015-07-10 |
Family
ID=40325992
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN2819KON2011 IN2011KN02819A (https=) | 2008-12-12 | 2009-12-08 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US8691215B2 (https=) |
| EP (1) | EP2355834B1 (https=) |
| CN (1) | CN102256611B (https=) |
| AU (1) | AU2009326204B2 (https=) |
| CA (1) | CA2746495C (https=) |
| DK (1) | DK2355834T3 (https=) |
| ES (1) | ES2423193T3 (https=) |
| GB (1) | GB0822672D0 (https=) |
| IN (1) | IN2011KN02819A (https=) |
| PL (1) | PL2355834T3 (https=) |
| WO (1) | WO2010067109A1 (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2007253033B2 (en) * | 2006-05-24 | 2013-01-24 | The University Of Warwick | Defective interfering virus |
| GB2522615A (en) * | 2014-01-16 | 2015-08-05 | Univ Warwick | Assay and medicament |
| CN112424367A (zh) * | 2018-04-26 | 2021-02-26 | 香港大学 | 具有抗病毒活性和递送活性的核酸分子和双功能肽，其组合物和方法 |
| GB202209861D0 (en) * | 2022-07-05 | 2022-08-17 | Univ Court Univ St Andrews | Viral vectors |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8715940B2 (en) | 1999-04-06 | 2014-05-06 | Wisconsin Alumni Research Foundation | Method of making recombinant influenza virus |
| EP2769735B1 (en) | 2004-10-06 | 2017-04-19 | MedImmune, LLC | Refrigerator-temperature stable influenza vaccine compositions |
| EP1812564A2 (en) | 2004-11-11 | 2007-08-01 | Solvay Pharmaceuticals B.V. | Defective influenza virus particles |
| AU2007253033B2 (en) | 2006-05-24 | 2013-01-24 | The University Of Warwick | Defective interfering virus |
| GB2437799B (en) | 2006-05-24 | 2008-08-13 | Univ Warwick | Defective interfering virus |
-
2008
- 2008-12-12 GB GBGB0822672.2A patent/GB0822672D0/en active Pending
-
2009
- 2009-12-08 CN CN200980149732.4A patent/CN102256611B/zh active Active
- 2009-12-08 US US13/132,593 patent/US8691215B2/en active Active
- 2009-12-08 ES ES09774920T patent/ES2423193T3/es active Active
- 2009-12-08 AU AU2009326204A patent/AU2009326204B2/en not_active Ceased
- 2009-12-08 IN IN2819KON2011 patent/IN2011KN02819A/en unknown
- 2009-12-08 CA CA2746495A patent/CA2746495C/en active Active
- 2009-12-08 DK DK09774920.4T patent/DK2355834T3/da active
- 2009-12-08 PL PL09774920T patent/PL2355834T3/pl unknown
- 2009-12-08 WO PCT/GB2009/051666 patent/WO2010067109A1/en not_active Ceased
- 2009-12-08 EP EP09774920.4A patent/EP2355834B1/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| EP2355834A1 (en) | 2011-08-17 |
| WO2010067109A1 (en) | 2010-06-17 |
| CA2746495A1 (en) | 2010-06-17 |
| EP2355834B1 (en) | 2013-05-01 |
| DK2355834T3 (da) | 2013-07-29 |
| AU2009326204A1 (en) | 2011-06-23 |
| CN102256611A (zh) | 2011-11-23 |
| AU2009326204B2 (en) | 2014-01-09 |
| PL2355834T3 (pl) | 2014-03-31 |
| US8691215B2 (en) | 2014-04-08 |
| CN102256611B (zh) | 2014-05-21 |
| CA2746495C (en) | 2018-04-17 |
| GB0822672D0 (en) | 2009-01-21 |
| ES2423193T3 (es) | 2013-09-18 |
| US20110243896A1 (en) | 2011-10-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX342995B (es) | Métodos de generar células asesinas naturales. | |
| EA201391519A1 (ru) | 2'-замещенные нуклеозидные производные и способы их применения для лечения вирусных заболеваний | |
| CY1114356T1 (el) | Αναστολεις του ιου της ηπατιτιδας c | |
| WO2013039861A3 (en) | Engineered nucleic acids and methods of use thereof | |
| EA201100390A1 (ru) | Соединения для лечения гепатита с | |
| MX2012004032A (es) | Compuestos para el tratamiento de hepatitis c. | |
| UA90048C2 (ru) | Кондиционированная композиция и способ ее получения | |
| WO2012142093A3 (en) | 2'-cyano substituted nucleoside derivatives and methods of use thereof for the treatment of viral diseases | |
| WO2009129470A3 (en) | Methods for treating herpes virus infections | |
| MX2012000034A (es) | Metodos para el tratamiento o la prevencion de la fatiga. | |
| EA201001691A1 (ru) | Антитела к гранулоцитарно-макрофагальному колониестимулирующему фактору | |
| ATE547118T1 (de) | Rekombinanter koi-herpesvirus (khv) oder cyprinid-herpesvirus 3 (cyhv-3) und impfstoff zur prävention einer von khv/cyhv-3 bei cyprinus carpio carpio oder cyprinus carpio koi verursachten erkrankung | |
| MX2012007166A (es) | Composicion antiviral sinergica y su uso. | |
| CA2904533C (en) | Enhanced osteogenic activity of daidzein analogs on human mesenchymal stem cells | |
| MX2014000567A (es) | Tratamiento de lesion por radiacion utilizando celulas adherentes derivadas del amnios. | |
| AU2012388759A8 (en) | Methods and compositions for hypotensive resuscitation | |
| PH12016500465A1 (en) | Deoxynojirimycin derivatives and methods of their using | |
| ATE555108T1 (de) | Polyamide zur behandlung des menschlichen papilloma-virus | |
| EP2601967A4 (en) | MEDICINE FOR PREVENTING AND TREATING HIV-RELATED OR HIV-RELATED DISEASES, INCLUDING AIDS | |
| IL207623A0 (en) | New clone of newcastle disease virus, its manufacture and its application in the medical treatment of cancer | |
| IN2011KN02819A (https=) | ||
| MX2013003245A (es) | Vacuna contra virus de diarrea viral de bovinos. | |
| WO2010138419A3 (en) | Materials and methods for treating viral infections | |
| EA201390925A1 (ru) | Производные санглиферина и способы их получения | |
| WO2010028072A3 (en) | Avian antibodies specific to influenza virus and technologically simple methods of their manufacture and use |